ADALIMUMAB GROUP I, LINE ITEMS 1 AND 2 AND GROUP II LINE ITEMS 1 AND 2. AWARDED FOR A BASE YEAR OF 3/9/2024 TO 3/8/2025 PLUS FOUR ONE YEAR OPTION PERIODS.
$325,063,436
| Recipient | ORGANON LLC UEI QTT6LXC3YKE9 |
|---|---|
| Award ID | 36E79724D0015 |
| Award amount | $325,063,436 |
| Award type | — |
| Awarding agency | Department of Veterans Affairs — Department of Veterans Affairs |
| NAICS | 325412 — PHARMACEUTICAL PREPARATION MANUFACTURING |
| PSC | 6505 |
| Start date | Mar 9, 2024 |
| End date | — |
| Place of performance | — |
| Record updated | Mar 28, 2024 |
View the official award record
More awards won by ORGANON LLC
NEW AWARD FOR RENFLEXIS (INFLIXIMAB-ABDA) 100MG VIAL WITH ORGANON LLC. ORDERING PERIOD IS SEPTEMBER 1, 2023 TO AUGUST 31, 2024 WITH FOUR ONE-YEAR OPTIONS.
Department of Veterans Affairs · $119,538,562 · Sep 1, 2023
65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, FSS CONTRACT AWARD
Department of Veterans Affairs · $750,000 · Jan 15, 2022
Our catalog shows awards of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.
Awards tell you who won. Bids tell you what's next. BidCatch scans 100+ federal, state, and local sources every night and sends the new opportunities matching your trade — before they're awarded to someone else. Free for 14 days, then $49.99/month.
Search open bids